Malignant Ovarian Epithelial Tumor — Trials

Malignant Ovarian Epithelial Tumor — Trials · CancerIndex

Clinical trials

Registered studies

897 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 270
Recruiting: 140
Ph III recruiting: 16
Growth YoY: +23.1%
Industry share: 31%
Top sponsor: National Cancer Institute (NCI)
Termination share: 38.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (145)

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07790939	89Zr-DFO-Mirvetuximab PET/CT Imaging for Companion Diagnosis and Response Evaluation in Ovarian Cancer	not yet recruiting	Early Phase 1	20	Peking University Cancer Hospital & InstituteOTHER	0	Aug 27, 2026	clinicaltrials
NCT04147494	Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues	active not recruiting	Early Phase 1	29	Jonsson Comprehensive Cancer CenterOTHER	1	Aug 21, 2026